Evaluation of Which Reactive Metabolite, If Any, Is Responsible for a Specific Idiosyncratic Reaction
Author:
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 38 (4) , 745-753
Abstract
Reactive metabolites are believed to be responsible for most idiosyncratic drug reactions. It is often assumed that if a reactive metabolite is found, it must be responsible for the idiosyncratic reactions associated with that drug. However, the evidence linking reactive metabolites and idiosyncratic reactions is circumstantial at best, and in many cases we have virtually no evidence. Furthermore, it is common for a drug to form several reactive metabolites, so it can be difficult to determine which, if any, is responsible for a given idiosyncratic reaction. Although the reactive metabolite hypothesis is logical, it has important implications for drug development, and we need to develop ways to test the hypothesis for specific drugs rigorously. Valid animal models are a powerful tool for testing whether a specific reactive metabolite is responsible for a specific adverse reaction and for studying further the mechanism by which it may induce such reactions; however, such models are rare.Keywords
This publication has 26 references indexed in Scilit:
- Kinetics of tienilic acid bioactivation and functional generation of drug–protein adducts in intact rat hepatocytesBiochemical Pharmacology, 2005
- A SIMPLE SEQUENTIAL INCUBATION METHOD FOR DECONVOLUTING THE COMPLICATED SEQUENTIAL METABOLISM OF CAPRAVIRINE IN HUMANSDrug Metabolism and Disposition, 2005
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Drug−Protein Adducts: An Industry Perspective on Minimizing the Potential for Drug Bioactivation in Drug Discovery and DevelopmentChemical Research in Toxicology, 2003
- Electrospray Ionization Mass Spectrometric Analysis of Intact Cytochrome P450: Identification of Tienilic Acid Adducts to P450 2C9Biochemistry, 1999
- Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivityBiochemical Pharmacology, 1995
- Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactionsPharmacogenetics, 1994
- Specificity of in vitro Covalent Binding of Tienilic Acid Metabolites to Human Liver Microsomes in Relationship to the Type of Hepatotoxicity: Comparison with Two Directly Hepatotoxic DrugsChemical Research in Toxicology, 1994
- Halothane hepatitis patients have serum antibodies that react with protein disulfide isomeraseHepatology, 1993
- STUDIES ON THE SENSITIZATION OF ANIMALS WITH SIMPLE CHEMICAL COMPOUNDSJournal of Experimental Medicine, 1935